We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Verona Pharma Plc | LSE:VRP | London | Ordinary Share | GB00BYW2KH80 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 55.00 | 45.00 | 65.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMVRP
RNS Number : 3484Y
Verona Pharma PLC
02 March 2017
Verona Pharma plc
PDMR Dealing
1 Details of the person discharging managerial responsibilities/person closely associated ---- ---------------------------------------------------------------------------------------------------------------- a) Name Dr. Jan-Anders Karlsson ---- ------------------------------------------------------- ------------------------------------------------------- 2 Reason for the notification ---- ---------------------------------------------------------------------------------------------------------------- Chief Executive Officer a) Position/status ---- ------------------------------------------------------- ------------------------------------------------------- b) Initial notification/Amendment Initial notification ---- ------------------------------------------------------- ------------------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---- ---------------------------------------------------------------------------------------------------------------- a) Name Verona Pharma plc ---- ------------------------------------------------------- ------------------------------------------------------- b) LEI n/a ---- ------------------------------------------------------- ------------------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---- ---------------------------------------------------------------------------------------------------------------- a) Description of the financial instrument, type of Ordinary Shares of 5 pence each instrument GB00BYW2KH80 Identification code ---- ------------------------------------------------------- ------------------------------------------------------- b) Nature of the transaction Jan-Anders Karlsson purchased 19,750 Ordinary Shares ---- ------------------------------------------------------- ------------------------------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) -------------- --------------- 149 pence 12,000 per Ordinary Ordinary Share Shares -------------- --------------- 149 pence 7,750 Ordinary per Ordinary Shares Share -------------- --------------- ---- ------------------------------------------------------- ------------------------------------------------------- d) Aggregated information 19,750 Ordinary Shares at 149 pence per Ordinary Share - Aggregated volume - Price ---- ------------------------------------------------------- ------------------------------------------------------- e) Date of the transaction 12,000 Ordinary Shares on 28 February 2017 and 7,750 Ordinary Shares on 1 March 2017 ---- ------------------------------------------------------- ------------------------------------------------------- f) Place of the transaction London Stock Exchange, AIM ---- ------------------------------------------------------- -------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEANDAEDFXEEF
(END) Dow Jones Newswires
March 02, 2017 04:36 ET (09:36 GMT)
1 Year Verona Pharma Chart |
1 Month Verona Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions